Background: Each year, family caregivers help the 2 million patients newly diagnosed with #Cancer manage their symptoms; however, few interventions have been developed and proven efficacious to enhance their symptom-support role. The recent expansion of electronic patient-reported outcomes (ePROs), including remote symptom monitoring, presents an opportunity to explore novel approaches to supporting caregiver symptom management by leveraging patient ePRO data. Objective: The objective of this study was to elicit feedback on a theory-based intervention concept, called FamilyAWARE, consisting of one-on-one coaching on providing effective symptom support to patients and access to a web-based dashboard reporting summaries of their care recipient’s most recent ePRO symptom reports and tailored recommendations. Methods: This was a qualitative formative evaluation study (National Institutes of Health stage IA) where family caregivers (n=20), patients with stage I to IV #Cancer (n=20), and oncology clinicians (n=25) were recruited from a comprehensive #Cancer center in the US South and participated in semistructured, one-on-one interviews (January 2025-July 2025). Participants were shown an outline of the FamilyAWARE intervention concept and asked open-ended questions about the proposed content, format, and delivery of the intervention. Professionally transcribed interviews were analyzed using a thematic analysis approach. Results: Analysis yielded 4 primary themes. The first theme was first impressions and relevance. Participants’ initial impressions of FamilyAWARE were generally positive, with caregivers viewing it as highly relevant and potentially beneficial. Patients and clinicians expressed more cautious optimism, shaped by considerations of relevance and minimizing burden. The second theme was key factors for acceptability and engagement. Caregivers showed strong interest in the intervention’s potential to increase confidence in symptom support; however, engagement was seen as contingent on the perceived value, minimal burden, and flexible delivery of the intervention, particularly given time and technology constraints. The third theme was coaching content and delivery. The proposed format was widely viewed as feasible. Participants emphasized content that helps caregivers balance supporting patients with promoting patient independence while also guiding them in deciding when to seek additional help and providing proactive symptom management strategies. Opinions on delivery by phone, in person, or videoconference varied. The fourth theme was dashboard design and information access. Participants emphasized the importance of a simple, mobile-friendly dashboard designed for low digital literacy, with plain language and visual cues. Caregiver access to patient symptom data was broadly supported if patient permission was obtained. Conclusions: Findings highlight strong interest and insights into designing a caregiver-focused intervention that integrates one-on-one coaching with ePRO patient symptom reports and tailored recommendations. Participant insights from this study will directly inform refinement of the intervention’s content, format, and delivery, with the goal of advancing it to pilot testing. Clinical Trial: N/A

Background: Electronic patient-reported outcomes (ePROs) can support patient-centered oncology care, but in early breast cancer, it is unclear whether real-time ePRO-triggered triage adds benefit beyond lower-intensity app-based support and scheduled ePRO collection. Objective: We tested whether adding weekly ePRO screening, rule-based triage, and care-team escalation to app-based support improves health-related quality of life (HRQoL) during systemic therapy for early breast cancer. Methods: ENABLE was a multicenter, open-label, parallel-group randomized controlled trial at 2 German university hospitals. Adults with early (stage I-III) breast cancer initiating systemic therapy were randomized 1:1 to reactive patient-reported outcome assessment (RPA) or control. Both arms received the ENABLE app with educational and organizational support and scheduled HRQoL assessments at 6 fixed time points; only RPA received weekly EuroQol Visual Analogue Scale screening (trigger: score

Background: #digital health solutions that incorporate electronic #Patient-reported outcomes (ePROs) hold promise for enhancing communication and #Patient engagement in pediatric #Oncology and palliative care. While ePROs are increasingly used in adult populations, their use in children, especially when combined with gamification, remains underexplored. Objective: This MyPal4Kids #Study aimed to assess the feasibility, acceptability, and user engagement of a #digital health platform that integrates ePROs and a serious game, designed for pediatric #Oncology #Patients aged 6‐17 years and their caregivers. Methods: A multicenter observational feasibility #Study was conducted between December 2020 and September 2022 at 3 clinical sites in Germany and the Czech Republic. A total of 83 children and adolescents with #Cancer, their parent or legal guardian, as well as 10 health care professionals (HCPs) participated. Primary outcomes included platform acceptability and engagement, assessed through recruitment, participation, and attrition rates, adherence, and usability ratings. Secondary outcomes focused on the feasibility of ePRO-based data capture and the perceived impact on HCP workflows and communication. A mixed methods design was used, combining in-app data and surveys with qualitative insights from focus groups. Results: The recruitment rate was 55%, with an attrition rate of 18%. Usability was rated positively, with most users finding the platform intuitive. Sustained engagement declined over time, particularly among older children who found the serious game insufficiently engaging. Adherence varied by age group and HCP involvement. Participants reported increased motivation when symptom reports were acknowledged by HCPs, although the impact on communication was perceived inconsistently. Conclusions: The developed platform shows potential for use in clinical care and research. However, maintaining long-term engagement remains a challenge. Tailoring content to different age groups and strengthening feedback mechanisms from HCPs are critical for improving the user experience. Successful implementation in routine clinical practice will require integration into existing workflows and #digital infrastructure, along with ongoing user-driven development. Trial Registration: DRKS DRKS00021458; https://drks.de/search/en/trial/DRKS00021458/details and ClinicalTrials.gov NCT04381221; https://clinicaltrials.gov/#Study/NCT04381221 and Universal Trial Number: U1111-1251-0043 International Registered Report Identifier (IRRID): RR2-10.1136/bmjopen-2020-045226

he OncoAlert🚨 #SABCS24 DAY2 Round Up REGISTER AT www.OncoAlert360.com OR https://buff.ly/48Xpgz0Discussing:✅EMBER3 (Out on @NEJM )✅Olympia✅PRO B✅ePROs✅SH...

Electronic patient-reported outcomes (ePROs) are increasingly important in modern clinical trials. ePRO can record how patients feel, function, and respond to treatment without needing site visits or paper reports. As studies focus more on patient outcomes and shift away from traditional models, ePRO offers a reliable way to collect real-time data from participants. This tool is vital for improving data quality, involving patients, and increasing efficiency in clinical research.

Objective The objective of this systematic review and meta-analysis (SRMA) was to evaluate the impact of electronic patient-reported outcomes (ePROs) on health-related quality of life (HRQoL) in patie...

Hi! I'm Epros, currently an amateur artist lurking for quite a while. . Art I may do: Inflation, Muscle and related stuffs. . This ...

Electronic patient-reported outcomes (ePROs) are increasingly important in modern clinical trials. ePRO can record how patients feel, function, and respond to treatment without needing site visits or paper reports. As studies focus more on patient outcomes and shift away from traditional models, ePRO offers a reliable way to collect real-time data from participants. This tool is vital for improving data quality, involving patients, and increasing efficiency in clinical research.

A new mobile health tool could represent a significant step forward in the aftercare of young women who have survived breast cancer.

Alt: the screaming kitten meme gif